MAY 26, 2020 1:39 PM PDT

Everyone Can Produce Antibodies Against COVID-19

WRITTEN BY: Annie Lennon

Researchers at Rockefeller University in New York have found that most people exposed to COVID-19, and who experience symptoms, can develop antibodies capable of blocking the virus. Their findings offer hope for the success of a potential vaccine, and research avenues for more drugs to combat it. 

Since April 1st, a team of researchers including immunologists, medical scientists, and virologists, has been collecting blood samples from people who have recovered from COVID-19. In total, they collected samples from 149 people over five weeks. Each participant experienced symptoms for an average of 12 days and had their first symptoms an average of 39 days before donating their blood. 

To test their antibodies, The researchers mixed their blood with a pseudo-COVID-19 virus in lab conditions. They then measured how well the mixture was then able to infect human cells in a petri dish. 

Although most of the samples had a poor to modest antibody response, closer inspection revealed that the problem was more to do with how many antibodies were present- as opposed to whether they were effective. Moreover, the researchers noted that those whose blood had antibodies below detectable levels might have been able to resolve the infection so quickly that the antibodies were not needed to be produced. 

"This suggests just about everybody can do this, which is very good news for vaccines," says Michel C. Nussenzweig, head of the Laboratory of Molecular Immunology at Rockefeller, and lead author of the study. "It means if you were able to create a vaccine that elicits these particular antibodies, then the vaccine is likely to be effective and work for a lot of people."

The researchers were also able to identify three distinct antibodies with a high potency against the virus. They are thus working on developing these antibodies into drugs both to treat and prevent COVID-19. 

 

Sources: bioRxiv, Medical Xpress

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 21, 2020
Cancer
Examining the Bioactive Components of an Alga Against Cancer
DEC 21, 2020
Examining the Bioactive Components of an Alga Against Cancer
Many of today’s drugs come from vast libraries of synthetic compounds built by chemists for big pharma. This drug ...
DEC 28, 2020
Cannabis Sciences
Does Cannabis Affect Stress in Men and Women Differently?
DEC 28, 2020
Does Cannabis Affect Stress in Men and Women Differently?
Researchers from Washington State University have found that cannabis may blunt the stress response differently in males ...
JAN 03, 2021
Drug Discovery & Development
How Psychedelic Salvinorin A Works in the Brain
JAN 03, 2021
How Psychedelic Salvinorin A Works in the Brain
Despite increasing interest in hallucinogens, the effects of Salvinorin A, a drug used in Native Mexican rituals, have r ...
JAN 19, 2021
Immunology
Food Allergies Be Gone: Nanoparticles Call for an Immune Ceasefire
JAN 19, 2021
Food Allergies Be Gone: Nanoparticles Call for an Immune Ceasefire
Milk, eggs, peanuts, tree nuts, wheat, soy, fish, and shellfish—these foods are among the most unwanted list for t ...
JAN 20, 2021
Drug Discovery & Development
Designer Cytokine: Potential Therapeutic Approach for Paralysis
JAN 20, 2021
Designer Cytokine: Potential Therapeutic Approach for Paralysis
Paralysis due to spinal cord damage remains an irreparable condition. However, a new therapeutic approach may bring rene ...
JAN 16, 2021
Drug Discovery & Development
Alternative Pain-Relief Bio-patch
JAN 16, 2021
Alternative Pain-Relief Bio-patch
Researchers develop a bio-compatible patch that releases non-opioid painkillers for days and potentially serving as a sa ...
Loading Comments...